https://www.selleckchem.com/pr....oducts/tenalisib-rp6
The NRS pain score is our primary and only outcome for block success. A minimum of 25 eligible patients are needed to achieve precise estimation of MEV90 with narrow 95% confidence intervals derived by bootstrapping. DISCUSSION Recruiting will begin June 2020 and is expected to finish November 2020. Data analysis will be performed at interims during and after the study. Results will be published in an international peer-reviewed medical journal. This article is protected by copyright. All rights reserved.INTRODUCTION Stability
Like
Comment
Share
